Mullan Pharmaceutical Inc.
37 drugs in NADAC|37 Generic,0 Brand
Mullan Pharmaceutical Inc. lists 37 NDCs in the CMS NADAC file (37 generic, 0 brand), at an average NADAC of $1.80 per unit, with a week-over-week move of +1.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
37
37G / 0B
Avg Price / Unit
$1.7982
$0.01 – $62.35
Avg 7d Change
+1.26%
Across 36 drugs with changes
7d Activity
of 37 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Gabapentin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Biguanide therapeutic class
Review the broader class where Mullan Pharmaceutical Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Mullan Pharmaceutical Inc. make?
Mullan Pharmaceutical Inc. lists 37 NDCs in the CMS NADAC file — 37 generic and 0 brand products.
What is the average price of Mullan Pharmaceutical Inc. drugs?
The average NADAC across Mullan Pharmaceutical Inc.'s portfolio is $1.7982 per unit, ranging from $0.0145 to $62.3467.
What types of drugs does Mullan Pharmaceutical Inc. make?
Mullan Pharmaceutical Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Biguanide (9), Aminoketone (8), Nonsteroidal Anti-inflammatory Drug (5), Gonadotropin Releasing Hormone Receptor Antagonist (1), Aminoglycoside Antibacterial (1).
Has Mullan Pharmaceutical Inc. had any drug recalls?
No FDA enforcement recalls are matched to Mullan Pharmaceutical Inc. in the openFDA feed.
How has Mullan Pharmaceutical Inc.'s pricing changed recently?
Over the past 7 days, 24 Mullan Pharmaceutical Inc. products rose and 12 fell, with a portfolio-wide average change of +1.3%.